Clinical Trial Update: P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reporting completion of studies evaluating Cefepime/Nacubactam and Aztreonam/Nacubactam vs best available therapy for adults wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Complicated Urinary Tract Infection
• Hospital-acquired Pneumonia
• Pyelonephritis
• Ventilator-associated Pneumonia

Drugs mentioned

• Aztreonam/Nacubactam (aztreonam/nacubactam)
• Cefepime/Nacubactam (cefepime/nacubactam)

Snippet

Sponsor: Meiji Seika Pharma Co., Ltd. | Conditions: Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 3 | Status: COMPLETED